文献速递糖尿病

多人群蛋白质组学分析改进2型糖尿病风险预测并识别新药靶点

Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes.
PubMed 文献 · Diabetes Care · 2024-01-01

在中国慢性病前瞻性研究(CKB)约2000名基线无糖尿病的随机参与者中,用Olink Explore检测2923种血浆蛋白,33种蛋白与2型糖尿病发病风险显著相关(FDR<0.05),加入这些蛋白使AUC从0.77升至0.88、NRI提高38%;孟德尔随机化支持ENTR1、LPL和PON3与2型糖尿病的因果关联。

要点

  • 33种血浆蛋白与2型糖尿病发病风险显著相关(FDR<0.05),包括IGFBP1、GHR和淀粉酶。
  • 将33种蛋白加入传统风险预测模型使AUC从0.77(0.73-0.82)升至0.88(0.85-0.91),NRI提高38%。
  • 孟德尔随机化支持ENTR1、LPL和PON3与2型糖尿病的因果关联,LPL和PON3共定位证据强(pH4>0.6)。

核心结论

  • 在中国成人中开展蛋白质组学分析,发现多种蛋白与2型糖尿病的新关联,并获强遗传学证据支持其因果关联及作为2型糖尿病预防和治疗新药靶点的潜力。

研究设计与样本

  • 从中国慢性病前瞻性研究(CKB)基线无糖尿病的参与者中随机选取约2000人,用Olink Explore检测2923种血浆蛋白水平。
  • 采用Cox回归评估单个蛋白与2型糖尿病发病的关联(92例发病)。
  • 构建基于蛋白质组的风险模型,分别用曲线下面积(AUC)、校准图和净重分类指数(NRI)评估区分度、校准和重分类。
  • 利用CKB和UK Biobank全基因组关联研究识别的特定蛋白顺式蛋白数量性状位点,进行两样本孟德尔随机化(MR)分析评估因果关联,并用共定位分析检查蛋白与2型糖尿病间的共享因果变异。

主要发现

  • 33种蛋白与2型糖尿病发病风险显著相关(错误发现率<0.05),包括IGFBP1、GHR和淀粉酶。
  • 将这33种蛋白加入传统风险预测模型,AUC从0.77(0.73-0.82)升至0.88(0.85-0.91),NRI提高38%,预测风险与观察风险校准良好。
  • 孟德尔随机化分析支持ENTR1、LPL和PON3与2型糖尿病的因果关联,并在欧洲人中用不同遗传工具重复了ENTR1和LPL的结果。
  • 共定位分析显示LPL和PON3与2型糖尿病共享遗传变异的强证据(pH4>0.6)。

关键数值与推荐

  • 33种蛋白与2型糖尿病发病风险显著相关(错误发现率<0.05)。
  • 加入33种蛋白后AUC从0.77(0.73-0.82)升至0.88(0.85-0.91),NRI提高38%。
  • 孟德尔随机化支持ENTR1、LPL和PON3与2型糖尿病的因果关联,ENTR1和LPL在欧洲人中重复。
  • 共定位分析显示LPL和PON3与2型糖尿病共享遗传变异的强证据(pH4>0.6)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Integrated analyses of plasma proteomics and genetic data in prospective studies can help assess the causal relevance of proteins, improve risk prediction, and discover novel protein drug targets for type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: We measured plasma levels of 2,923 proteins using Olink Explore among ∼2,000 randomly selected participants from China Kadoorie Biobank (CKB) without prior diabetes at baseline. Cox regression assessed associations of individual protein with incident T2D (n = 92 cases). Proteomic-based risk models were developed with discrimination, calibration, reclassification assessed using area under the curve (AUC), calibration plots, and net reclassification index (NRI), respectively. Two-sample Mendelian randomization (MR) analyses using cis-protein quantitative trait loci identified in a genome-wide association study of CKB and UK Biobank for specific proteins were conducted to assess their causal relevance for T2D, along with colocalization analyses to examine shared causal variants between proteins and T2D. RESULTS: Overall, 33 proteins were significantly associated (false discovery rate <0.05) with risk of incident T2D, including IGFBP1, GHR, and amylase. The addition of these 33 proteins to a conventional risk prediction model improved AUC from 0.77 (0.73-0.82) to 0.88 (0.85-0.91) and NRI by 38%, with predicted risks well calibrated with observed risks. MR analyses provided support for the causal relevance for T2D of ENTR1, LPL, and PON3, with replication of ENTR1 and LPL in Europeans using different genetic instruments. Moreover, colocalization analyses showed strong evidence (pH4 > 0.6) of shared genetic variants of LPL and PON3 with T2D. CONCLUSIONS: Proteomic analyses in Chinese adults identified novel associations of multiple proteins with T2D with strong genetic evidence supporting their causal relevance and potential as novel drug targets for prevention and treatment of T2D.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Yao P, Iona A, Pozarickij A, et al. Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes. Diabetes Care. 2024. PMID: 38623619. doi:10.2337/dc23-2145

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。